The bill, known as Engrossed Senate Bill No. 176, establishes new requirements for health benefit plans regarding coverage for contraceptive drugs. It defines "contraceptive drugs" as those approved by the FDA for pregnancy prevention and outlines that any health benefit plan offered, issued, or renewed after the effective date must provide coverage for a three-month supply of a contraceptive drug upon the first request and a six-month supply for subsequent requests. This coverage is applicable regardless of whether the enrollee was previously enrolled in the plan when they first obtained the drug, with the stipulation that only one six-month supply can be obtained within a six-month period.

Additionally, the bill clarifies that enrollees can request smaller supplies of contraceptive drugs if deemed clinically appropriate, and it explicitly states that the coverage does not extend to medications intended to terminate an existing pregnancy. The act is set to take effect on November 1, 2025, following its passage in both the House and Senate.